Immune response enhancement with GLS-5310 DNA primary vaccine against SARS-CoV-2 followed by administration of an mRNA vaccine heterologous boost

Kim, WJ; Roberts, CC; Song, JY; Yoon, JG; Seong, H; Hyun, HJ; Lee, HYJ; Gil, A; Oh, Y; Park, JE; Lee, JE; Jeon, B; Kane, D; Spruill, S; Kudchodkar, SB; Muthumani, K; Park, YK; Kwon, I; Maslow, JN

Maslow, JN (通讯作者),GeneOne Life Sci Inc, Seoul, South Korea.

VACCINE, 2023; 41 (29): 4206

Abstract

Heterologous boost regimens are being increasingly considered against SARS-CoV-2. We report results for the 32 of 45 participants in the Phase 1 CoV2-......

Full Text Link